Effectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study

Abstract Background V-Go is a wearable, patch-like, 24-h insulin delivery device that delivers both a continuous preset basal rate and on-demand bolus dosing. The aim of this study was to observe glycemic control, insulin dosing, and hypoglycemia risk in patients switched to V-Go in a real-world set...

Full description

Bibliographic Details
Main Authors: George Grunberger, Cheryl R. Rosenfeld, Bruce W. Bode, Scott D. Abbott, Carla Nikkel, Leon Shi, Poul Strange
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-12-01
Series:Drugs - Real World Outcomes
Online Access:https://doi.org/10.1007/s40801-019-00173-8